Financials
- Market Capitalization 447.44 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
1.37
売上高対価格比率
0.76
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2742 | CBIO Crescent Biopharma, Inc. - Common Stock | 17.75 USD | -0.06% | +3.50% | +21.08% | +22.50% | 659.30 M USD | ||
| 2815 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD | ||
| 3145 | UPB Upstream Bio, Inc. - Common Stock | 6.69 USD | -1.47% | -4.43% | +5.35% | -59.84% | 366.42 M USD | ||
| 3336 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.97 USD | -0.71% | -0.85% | -1.13% | -10.22% | 295.09 M USD |